跳至主要内容
临床试验/EUCTR2013-003370-27-DE
EUCTR2013-003370-27-DE进行中(未招募)1 期

Functional MRI (fMRI) after challenge and treatment with antidepressants and their relation to the clinical course, to the Hypothalamus-Hypophysis-Adrenocortical Axis and the colon microbiome - fMRI, HPA-axis and gut microbiome during treatment with antidepressants

Rainer Rupprecht, Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg am Bezirksklinikum0 个研究点目标入组 80 人开始时间: 2014年7月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Male and female in-patients in the age between 18 and 65 years
  • Major depressive disorder
  • Admission on a voluntary basis independent of our study
  • Written informed consent for trial participation after the scope and nature of the investigation have been explained to the patients before starting trial-related activities.
  • Indication for antidepressant therapy independent of the clinical trial.
  • primary unipolar depression (ICD-10: F32, F33) or bipolar depression (ICD-10: F31.3-5), current episode of depressed state for at least 2 weeks prior to baseline
  • Physically healthy
  • Right handedness (assessed by the Edinburgh Handedness Inventory (Oldfield, 1971))
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 80
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • Schizophrenia, substance dependence as define by ICD-10 or any other psychiatric primary diagnosis (according to the ICD-10 criteria)
  • major somatic or neurological disorder
  • abnormalities in the laboratory screening at baseline (e.g. hypo- or hyperthyroid state, elevated liver enzymes, blood cell dyscrasias)
  • lacking ability to give informed consent
  • have been admitted to the clinic involuntarily during their present episode
  • pregnancy or breast-feeding
  • in case of the inclusion of premenomausal female patients insufficient contraception leads to exclusion from the study
  • contraindications to magnetic resonance imaging patient with heart pacemaker or implanted metal in the scull
  • or concurrent medication, which could alter emotional processing
  • known history of alcohol or drug abuse during 6 month prior to the screening
  • being at clinically risk of suicidal behavior (HAM-D Item 3 > 2 or clinical impression)
  • involuntary admission to the hospital
  • known allergies or hypersensitivity reactions or other contraindications for escitalopram, agomelatin or mirtazapine
  • being treated with psychotropic medication < 3weeks before study (5weeks in case of fluoxetine pretreatment)
  • Unusual diets leading to malnutrition
  • Pretreatment with antibiotics or corticosteriods

研究者

发起方
Rainer Rupprecht, Klinik und Poliklinik für Psychiatrie und Psychotherapie der Universität Regensburg am Bezirksklinikum

相似试验